Saline Infusion Test in Hyponatremia
NCT06498856 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-07-12
Summary
Observational study of biochemical volume biomarker levels in response to a standardized intravenous isotonic saline infusion in patients with hyponatremia.
Conditions
Interventions
- OTHER
-
Isotonic saline infusion
Volume expansion with one liter of isotonic saline intravenously over two hours.
Sponsors & Collaborators
-
Hormone Laboratory, Aker University Hospital, Oslo, Norway
collaborator OTHER -
University Hospital, Akershus
lead OTHER
Principal Investigators
-
Jacob A Winther, MD,PHD · University Hospital, Akershus
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-07-31
- Primary Completion
- 2025-12-31
- Completion
- 2028-12-31
More Related Trials
-
Low-dose Tolvaptan for Inpatient Hyponatraemia.
NCT06171100 ·Status: RECRUITING
-
An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH
NCT02545101 ·Status: COMPLETED
-
International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430
NCT01056848 ·Status: COMPLETED
-
Urea for Chronic Hyponatremia
NCT04588207 ·Status: TERMINATED ·Phase: PHASE2
-
The Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia
NCT01509170 ·Status: UNKNOWN
-
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia
NCT00660959 ·Status: COMPLETED ·Phase: PHASE3
-
"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
NCT00072683 ·Status: COMPLETED ·Phase: PHASE3
-
Measurement of Sweat Sodium Concentration in Patients With Chronic Kidney Disease
NCT06354842 ·Status: COMPLETED
-
Effects of Tolvaptan in Healthy Adults
NCT01973140 ·Status: COMPLETED ·Phase: PHASE4
-
Urine Chloride/Creatinine Ratio for Estimation of Urine Sodium
NCT00324883 ·Status: COMPLETED
-
Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA)
NCT01638663 ·Status: COMPLETED ·Phase: PHASE2
-
Targeted Correction of Plasma Sodium Levels in Hospitalized Patients With Hyponatremia
NCT03557957 ·Status: COMPLETED ·Phase: NA
-
Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia
NCT00380575 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnosing Natriuretic Peptide Deficiency
NCT03035929 ·Status: COMPLETED ·Phase: PHASE1
-
Water Load Test Value for Hyponatremia
NCT04256499 ·Status: COMPLETED
-
Acute Salt Handling in Orthostatic Intolerance
NCT00581633 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
"SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
NCT00201994 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Thiazide, Amiloride and Hypertonic Saline on Urinary Biomarkers in Healthy Subjects
NCT01635231 ·Status: COMPLETED ·Phase: NA
-
Validation of New Diagnostic Indices to Simplify Hyponatremia Therapy Assessment in Patients on Thiazide Diuretics
NCT06381934 ·Status: RECRUITING ·Phase: NA
-
Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide
NCT02399358 ·Status: UNKNOWN
-
International, Multicenter, Open-Label and Randomized Withdrawal Study of Oral Lixivaptan in Heart Failure Patients With Chronic Hyponatremia
NCT00876876 ·Status: WITHDRAWN ·Phase: PHASE3
-
Relation Between COVID-19 Pts and Hyponatremia in Adreno Ortical Insufficient Patients.
NCT05408481 ·Status: UNKNOWN
-
The Diagnostic Performance of 24-hour Urinary Aldosterone for Primary Aldosteronism
NCT06236698 ·Status: COMPLETED
-
Simplification of Oral Sodium Loading Test in the Diagnosis of Primary Aldosteronism: 2-day Replacing 3-day Method
NCT06750172 ·Status: RECRUITING
-
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia
NCT00876798 ·Status: COMPLETED ·Phase: PHASE3